dz

dz dz

sq 中文
电话 0731-85681666-8006

dz

1
current position：
Homepage
/
发展历程
/
Approved Drugs
/
On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2021-11-22 13:56
  • Views:

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2021-11-22 13:56
  • Views:
Previous: On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved
Next: On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved
Previous: On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved
Next: On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved

Online

Online

TEL

0731-85681666-8006

WeChat

WeChat

TOP

搜索
Search
dz

Service Hotline：

0731-85681666-8006

Copyright © 2021 Changsha Duxact Biotech Co., Ltd.     湘ICP备 16006884号-1
www.300.cn      Changsha